Clinical Trial Update: Melatonin Oral Gel for Oral Mucositis in Patients With Head and Neck Cancer Undergoing Chemoradiation [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 clinical trial of Melatonin Oral Gel for oral mucositis in patients with head and neck cancer undergoing chemoradiation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Oral Mucositis

Drugs mentioned

• Melatonin Oral Gel (melatonin)

Snippet

Sponsor: Spherium Biomed | Conditions: Oral Mucositis | Phase 1, Phase 2 | Status: COMPLETED